In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...
The SURTAVI trial has become the second major face-off between transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively), after PARTNER 2A, to show parity in 5-year clinical ...
NEW YORK CITY -- Women with severe native aortic stenosis (AS) gained significantly better results from surgery with aortic annular enlargement (AAE) than transcatheter aortic valve replacement (TAVR) ...
Patients with cognitive impairment may experience greater improvements in cognition with transcatheter aortic valve replacement (TAVR) than with surgical aortic valve replacement (SAVR), new research ...
TAVR is not only safe but also potentially beneficial in patients with severe aortic stenosis who have been diagnosed with cancer, national US data suggest. Between 2012 and 2015, use of TAVR ...
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
Compared with a repeat surgical procedure, valve-in-valve (ViV) TAVR for failed bioprosthetic aortic valves results in better short-term outcomes, with no difference over time in major cardiovascular ...
Long Beach, Calif. – May 4, 2024 – A nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) who underwent transcatheter aortic valve replacement (TAVR) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results